{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "exchange": "HKG", "shortName": "SIMCERE PHARMA", "longName": "Simcere Pharmaceutical Group Limited", "messageBoardId": "finmb_33364824", "market": "hk_market", "marketState": "CLOSED", "earningsTimestamp": 1680273087, "earningsTimestampStart": 1680273087, "earningsTimestampEnd": 1680273087, "trailingAnnualDividendRate": 0.16, "trailingPE": 19.697674, "trailingAnnualDividendYield": 0.018823529, "epsTrailingTwelveMonths": 0.43, "epsForward": 0.61, "epsCurrentYear": 0.47, "priceEpsCurrentYear": 18.021276, "sharesOutstanding": 2660379904, "bookValue": 2.679, "fiftyDayAverage": 9.1714, "fiftyDayAverageChange": -0.7013998, "fiftyDayAverageChangePercent": -0.07647685, "twoHundredDayAverage": 9.455, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Hong_Kong", "exchangeTimezoneShortName": "HKT", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -0.35293803, "regularMarketPrice": 8.47, "regularMarketChange": -0.029999733, "regularMarketTime": 1683878916, "regularMarketDayHigh": 8.63, "regularMarketDayRange": "8.44 - 8.63", "regularMarketDayLow": 8.44, "regularMarketVolume": 2858000, "regularMarketPreviousClose": 8.5, "bid": 8.46, "ask": 8.48, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 8.53, "averageDailyVolume3Month": 7873498, "averageDailyVolume10Day": 4349151, "fiftyTwoWeekLowChange": 1.9100003, "fiftyTwoWeekLowChangePercent": 0.2911586, "fiftyTwoWeekRange": "6.56 - 14.7", "fiftyTwoWeekHighChange": -6.2299995, "fiftyTwoWeekHighChangePercent": -0.4238095, "fiftyTwoWeekLow": 6.56, "fiftyTwoWeekHigh": 14.7, "twoHundredDayAverageChange": -0.98499966, "twoHundredDayAverageChangePercent": -0.10417765, "marketCap": 22533419008, "forwardPE": 13.885246, "priceToBook": 3.1616278, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "ipoExpectedDate": "2020-10-16", "prevName": "Simcere Pharmaceutical Group.", "nameChangeDate": "2023-05-12", "averageAnalystRating": "1.5 - Strong Buy", "firstTradeDateMilliseconds": 1603762200000, "priceHint": 3, "symbol": "2096.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 699-18, Xuanwu Road", "address2": "Xuanwu District", "city": "Nanjing", "zip": "210042", "country": "China", "phone": "86 25 8556 6666", "fax": "86 25 8526 2330", "website": "https://www.simcere.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets. The company also offers promotion services for pharmaceutical products. It has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region. In addition, the company engages in the manufacture of pharmaceutical ingredients; and property management business. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.", "fullTimeEmployees": 7832, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jinsheng  Ren", "age": 60, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 418024, "fmt": "418.02k", "longFmt": "418,024"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yushan  Wan", "age": 52, "title": "CFO, Joint Company Sec. & Exec. Director", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 1000364, "fmt": "1M", "longFmt": "1,000,364"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Renhong  Tang Ph.D.", "age": 41, "title": "Exec. Director", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": {"raw": 1943450, "fmt": "1.94M", "longFmt": "1,943,450"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Quanfu  Feng", "age": 57, "title": "VP of Marketing", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kevin  Oliver Ph.D.", "age": 52, "title": "Sr. VP", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bijoyesh  Mookerjee M.D.", "age": 60, "title": "Chief Medical Officer of Oncology", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Danny  Chen Ph.D.", "age": 54, "title": "Senor VP", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tong  Zhu", "age": 44, "title": "Chief Operating Officer of Simcere Zaiming", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tamas  Oravecz Ph.D.", "title": "Sr. VP & Chief Scientific Officer of  U.S.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Song  Wenjie", "age": 44, "title": "Sr. VP of Simcere Zaiming", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}